> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# GCP Workshop Considerations
- URL: https://www.fdaweb.com/gcp-workshop-considerations/
- Published: 2020-01-28T12:00:00.000Z
- Updated: 2026-09-14T16:00:14.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145944

Discussions from a 10/2018 joint good clinical practice workshop held by FDA and the UK Medicines and Healthcare Products Regulatory Agency have been [published](https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1794?ref=fdaweb.com) in the journal of the American Society for Clinical Pharmacology and Therapeutics. The article says the workshop “provided the agencies’ perspectives on the importance of data quality management practices on data integrity. Regulatory perspectives on data blinding to minimize introduction of bias, and the role of audit trails in assessing data integrity in global clinical trials were discussed.”